Cargando…
Administration of B7-H3 targeted chimeric antigen receptor-T cells induce regression of glioblastoma
Autores principales: | Tang, Xin, Wang, Yuelong, Huang, Jianhan, Zhang, Zongliang, Liu, Fujun, Xu, Jianguo, Guo, Gang, Wang, Wei, Tong, Aiping, Zhou, Liangxue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994554/ https://www.ncbi.nlm.nih.gov/pubmed/33767145 http://dx.doi.org/10.1038/s41392-021-00505-7 |
Ejemplares similares
-
Bioactivity and safety of B7‐H3‐targeted chimeric antigen receptor T cells against anaplastic meningioma
por: Tang, Xin, et al.
Publicado: (2020) -
B7-H3 as a Novel CAR-T Therapeutic Target for Glioblastoma
por: Tang, Xin, et al.
Publicado: (2019) -
B7-H3-Targeted CAR-T Cells Exhibit Potent Antitumor Effects on Hematologic and Solid Tumors
por: Zhang, Zongliang, et al.
Publicado: (2020) -
Fn14-targeted BiTE and CAR-T cells demonstrate potent preclinical activity against glioblastoma
por: Li, Gaowei, et al.
Publicado: (2021) -
Tumor-associated microglia and macrophages in glioblastoma: From basic insights to therapeutic opportunities
por: Wang, Guoqing, et al.
Publicado: (2022)